Medical - Diagnostics & Research
Compare Stocks
5 / 10Stock Comparison
CHEK vs AEYE vs ALKT vs GXAI vs MSFT
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Software - Application
Electronic Gaming & Multimedia
Software - Infrastructure
CHEK vs AEYE vs ALKT vs GXAI vs MSFT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Diagnostics & Research | Software - Application | Software - Application | Electronic Gaming & Multimedia | Software - Infrastructure |
| Market Cap | $12M | $100M | $1.87B | $2M | $3.13T |
| Revenue (TTM) | $0.00 | $40M | $472M | $694K | $318.27B |
| Net Income (TTM) | $-25M | $-3M | $-50M | $-4M | $125.22B |
| Gross Margin | — | 78.3% | 57.4% | 79.2% | 68.3% |
| Operating Margin | — | -7.9% | -9.3% | -6.6% | 46.8% |
| Forward P/E | — | — | 21.7x | — | 25.3x |
| Total Debt | $136K | $721K | $354M | $0.00 | $112.18B |
| Cash & Equiv. | — | $5M | $63M | $14M | $30.24B |
CHEK vs AEYE vs ALKT vs GXAI vs MSFT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 23 | Jan 26 | Return |
|---|---|---|---|
| Check-Cap Ltd. (CHEK) | 100 | 63.0 | -37.0% |
| AudioEye, Inc. (AEYE) | 100 | 144.4 | +44.4% |
| Alkami Technology, … (ALKT) | 100 | 150.2 | +50.2% |
| Gaxos.ai Inc. (GXAI) | 100 | 4.2 | -95.8% |
| Microsoft Corporati… (MSFT) | 100 | 193.9 | +93.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CHEK vs AEYE vs ALKT vs GXAI vs MSFT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CHEK has the current edge in this matchup, primarily because of its strength in quality and momentum.
- 212.2% margin vs GXAI's -5.4%
- +112.2% vs ALKT's -37.8%
Among these 5 stocks, AEYE doesn't own a clear edge in any measured category.
ALKT is the clearest fit if your priority is value.
- Better valuation composite
GXAI is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 14.7%, EPS growth 52.0%
- Lower volatility, beta 0.53, current ratio 41.91x
- Beta 0.53, current ratio 41.91x
- 14.7% revenue growth vs CHEK's -48.5%
MSFT ranks third and is worth considering specifically for income & stability and long-term compounding.
- Dividend streak 19 yrs, beta 0.89, yield 0.8%
- 7.9% 10Y total return vs AEYE's 102.2%
- 0.8% yield; 19-year raise streak; the other 4 pay no meaningful dividend
- 19.2% ROA vs CHEK's -66.7%, ROIC 24.9% vs -287.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.7% revenue growth vs CHEK's -48.5% | |
| Value | Better valuation composite | |
| Quality / Margins | 212.2% margin vs GXAI's -5.4% | |
| Stability / Safety | Beta 0.53 vs AEYE's 2.29 | |
| Dividends | 0.8% yield; 19-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +112.2% vs ALKT's -37.8% | |
| Efficiency (ROA) | 19.2% ROA vs CHEK's -66.7%, ROIC 24.9% vs -287.7% |
CHEK vs AEYE vs ALKT vs GXAI vs MSFT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
CHEK vs AEYE vs ALKT vs GXAI vs MSFT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSFT leads in 2 of 6 categories
ALKT leads 1 • CHEK leads 1 • AEYE leads 0 • GXAI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — GXAI and MSFT each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MSFT and CHEK operate at a comparable scale, with $318.3B and $0 in trailing revenue. MSFT is the more profitable business, keeping 39.3% of every revenue dollar as net income compared to GXAI's -5.4%. On growth, GXAI holds the edge at +183.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $40M | $472M | $694,278 | $318.3B |
| EBITDAEarnings before interest/tax | -$26M | -$504,000 | -$12M | -$4M | $192.6B |
| Net IncomeAfter-tax profit | -$25M | -$3M | -$50M | -$4M | $125.2B |
| Free Cash FlowCash after capex | -$8,004 | $2M | $44M | -$4M | $72.9B |
| Gross MarginGross profit ÷ Revenue | — | +78.3% | +57.4% | +79.2% | +68.3% |
| Operating MarginEBIT ÷ Revenue | — | -7.9% | -9.3% | -6.6% | +46.8% |
| Net MarginNet income ÷ Revenue | — | -7.6% | -10.6% | -5.4% | +39.3% |
| FCF MarginFCF ÷ Revenue | — | +5.5% | +9.4% | -6.4% | +22.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +7.9% | +28.9% | +183.3% | +18.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -155.6% | +29.0% | -22.7% | +77.0% | +23.4% |
Valuation Metrics
ALKT leads this category, winning 2 of 5 comparable metrics.
Valuation Metrics
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $12M | $100M | $1.9B | $2M | $3.13T |
| Enterprise ValueMkt cap + debt − cash | $12M | $96M | $2.2B | -$12M | $3.21T |
| Trailing P/EPrice ÷ TTM EPS | -0.48x | -32.36x | -37.89x | -0.64x | 30.86x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 21.69x | — | 25.34x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 1.64x |
| EV / EBITDAEnterprise value multiple | — | — | — | — | 19.72x |
| Price / SalesMarket cap ÷ Revenue | — | 2.49x | 4.20x | 538.49x | 11.10x |
| Price / BookPrice ÷ Book value/share | — | 20.91x | 5.00x | 0.13x | 9.15x |
| Price / FCFMarket cap ÷ FCF | — | — | 45.09x | — | 43.66x |
Profitability & Efficiency
MSFT leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MSFT delivers a 33.1% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $-2 for CHEK. AEYE carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALKT's 0.98x. On the Piotroski fundamental quality scale (0–9), MSFT scores 6/9 vs CHEK's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.3% | -47.8% | -14.0% | -27.3% | +33.1% |
| ROA (TTM)Return on assets | -66.7% | -9.5% | -5.9% | -26.4% | +19.2% |
| ROICReturn on invested capital | -2.9% | -42.4% | -8.6% | -120.1% | +24.9% |
| ROCEReturn on capital employed | -2.3% | -17.7% | -9.3% | -36.9% | +29.7% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 | 3 | 4 | 6 |
| Debt / EquityFinancial leverage | — | 0.15x | 0.98x | — | 0.33x |
| Net DebtTotal debt minus cash | $136,000 | -$5M | $290M | -$14M | $81.9B |
| Cash & Equiv.Liquid assets | — | $5M | $63M | $14M | $30.2B |
| Total DebtShort + long-term debt | $136,000 | $721,000 | $354M | $0 | $112.2B |
| Interest CoverageEBIT ÷ Interest expense | -2883.22x | -2.79x | -3.73x | — | 55.65x |
Total Returns (Dividends Reinvested)
CHEK leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MSFT five years ago would be worth $17,246 today (with dividends reinvested), compared to $251 for GXAI. Over the past 12 months, CHEK leads with a +112.2% total return vs ALKT's -37.8%. The 3-year compound annual growth rate (CAGR) favors CHEK at 14.1% vs GXAI's -52.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +21.3% | -18.7% | -23.1% | +5.2% | -10.8% |
| 1-Year ReturnPast 12 months | +112.2% | -27.9% | -37.8% | +7.0% | -2.1% |
| 3-Year ReturnCumulative with dividends | +48.6% | +20.6% | +41.1% | -89.2% | +39.5% |
| 5-Year ReturnCumulative with dividends | -93.0% | -60.2% | -54.9% | -97.5% | +72.5% |
| 10-Year ReturnCumulative with dividends | -99.7% | +102.2% | -59.5% | -97.5% | +787.7% |
| CAGR (3Y)Annualised 3-year return | +14.1% | +6.4% | +12.2% | -52.4% | +11.7% |
Risk & Volatility
Evenly matched — GXAI and MSFT each lead in 1 of 2 comparable metrics.
Risk & Volatility
GXAI is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than AEYE's 2.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MSFT currently trades 75.8% from its 52-week high vs GXAI's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.67x | 2.29x | 1.30x | 0.53x | 0.89x |
| 52-Week HighHighest price in past year | $3.92 | $16.39 | $31.66 | $2.96 | $555.45 |
| 52-Week LowLowest price in past year | $0.59 | $5.31 | $14.11 | $1.02 | $356.28 |
| % of 52W HighCurrent price vs 52-week peak | +53.1% | +49.4% | +55.1% | +41.2% | +75.8% |
| RSI (14)Momentum oscillator 0–100 | 58.5 | 61.3 | 50.9 | 45.2 | 54.0 |
| Avg Volume (50D)Average daily shares traded | 2.5M | 194K | 1.9M | 5.9M | 32.5M |
Analyst Outlook
MSFT leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: ALKT as "Buy", MSFT as "Buy". Consensus price targets imply 31.1% upside for MSFT (target: $552) vs 26.2% for ALKT (target: $22). MSFT is the only dividend payer here at 0.77% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | — | Buy |
| Price TargetConsensus 12-month target | — | — | $22.00 | — | $551.75 |
| # AnalystsCovering analysts | — | — | 12 | — | 81 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +0.8% |
| Dividend StreakConsecutive years of raises | — | 1 | 1 | — | 19 |
| Dividend / ShareAnnual DPS | — | — | — | — | $3.23 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +0.9% | +0.6% |
MSFT leads in 2 of 6 categories (Profitability & Efficiency, Analyst Outlook). ALKT leads in 1 (Valuation Metrics). 2 tied.
CHEK vs AEYE vs ALKT vs GXAI vs MSFT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CHEK or AEYE or ALKT or GXAI or MSFT a better buy right now?
For growth investors, Gaxos.
ai Inc. (GXAI) is the stronger pick with 1473% revenue growth year-over-year, versus 14. 5% for AudioEye, Inc. (AEYE). Microsoft Corporation (MSFT) offers the better valuation at 30. 9x trailing P/E (25. 3x forward), making it the more compelling value choice. Analysts rate Alkami Technology, Inc. (ALKT) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CHEK or AEYE or ALKT or GXAI or MSFT?
On forward P/E, Alkami Technology, Inc.
is actually cheaper at 21. 7x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CHEK or AEYE or ALKT or GXAI or MSFT?
Over the past 5 years, Microsoft Corporation (MSFT) delivered a total return of +72.
5%, compared to -97. 5% for Gaxos. ai Inc. (GXAI). Over 10 years, the gap is even starker: MSFT returned +787. 7% versus CHEK's -99. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CHEK or AEYE or ALKT or GXAI or MSFT?
By beta (market sensitivity over 5 years), Gaxos.
ai Inc. (GXAI) is the lower-risk stock at 0. 53β versus AudioEye, Inc. 's 2. 29β — meaning AEYE is approximately 332% more volatile than GXAI relative to the S&P 500. On balance sheet safety, AudioEye, Inc. (AEYE) carries a lower debt/equity ratio of 15% versus 98% for Alkami Technology, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CHEK or AEYE or ALKT or GXAI or MSFT?
By revenue growth (latest reported year), Gaxos.
ai Inc. (GXAI) is pulling ahead at 1473% versus 14. 5% for AudioEye, Inc. (AEYE). On earnings-per-share growth, the picture is similar: Gaxos. ai Inc. grew EPS 52. 0% year-over-year, compared to -43. 3% for Check-Cap Ltd.. Over a 3-year CAGR, ALKT leads at 29. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CHEK or AEYE or ALKT or GXAI or MSFT?
Microsoft Corporation (MSFT) is the more profitable company, earning 36.
1% net margin versus -850. 3% for Gaxos. ai Inc. — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSFT leads at 45. 6% versus -919. 7% for GXAI. At the gross margin level — before operating expenses — GXAI leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CHEK or AEYE or ALKT or GXAI or MSFT more undervalued right now?
On forward earnings alone, Alkami Technology, Inc.
(ALKT) trades at 21. 7x forward P/E versus 25. 3x for Microsoft Corporation — 3. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MSFT: 31. 1% to $551. 75.
08Which pays a better dividend — CHEK or AEYE or ALKT or GXAI or MSFT?
In this comparison, MSFT (0.
8% yield) pays a dividend. CHEK, AEYE, ALKT, GXAI do not pay a meaningful dividend and should not be held primarily for income.
09Is CHEK or AEYE or ALKT or GXAI or MSFT better for a retirement portfolio?
For long-horizon retirement investors, Microsoft Corporation (MSFT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
89), 0. 8% yield, +787. 7% 10Y return). AudioEye, Inc. (AEYE) carries a higher beta of 2. 29 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MSFT: +787. 7%, AEYE: +102. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CHEK and AEYE and ALKT and GXAI and MSFT?
These companies operate in different sectors (CHEK (Healthcare) and AEYE (Technology) and ALKT (Technology) and GXAI (Technology) and MSFT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CHEK is a small-cap quality compounder stock; AEYE is a small-cap quality compounder stock; ALKT is a small-cap high-growth stock; GXAI is a small-cap high-growth stock; MSFT is a mega-cap quality compounder stock. MSFT pays a dividend while CHEK, AEYE, ALKT, GXAI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.